AddictionTreatment

Lilly Plans Trials for Obesity Drugs to Combat Addiction by 2025

13 days ago

In a groundbreaking announcement, Eli Lilly's CEO revealed that the pharmaceutical giant is set to initiate trials in 2025 to explore the potential use of its obesity drugs in treating addiction. This promising development stands as a pivotal moment in both obesity and addiction treatment landscapes.

Revolutionizing Overdose Prevention: The Potential of a Fentanyl Vaccine

2 months ago

The ongoing battle against the opioid epidemic, particularly the surge of fentanyl-related overdoses in recent years, is taking a hopeful turn with the development of a groundbreaking vaccine. Researchers are excited about the possibilities of a vaccine that could immunize individuals against the harmful effects of fentanyl, potentially saving thousands of lives. This innovative approach aims not only to reduce the risk of overdose but also to change the landscape of addiction treatment.